Oxidative Medicine and Cellular Longevity / 2015 / Article / Tab 2 / Research Article
The Effects of Age and Latent Cytomegalovirus Infection on NK-Cell Phenotype and Exercise Responsiveness in Man Table 2 Exercise-induced changes in NK-cell subset numbers in healthy adult males (
= 20;
= 20) contrasted by CMV serostatus and age. CMV
pos and CMV
neg participants are denoted by + and −, respectively. Main and interaction effects for CMV, age, and time are reported with significance connoted by
(
< 0.05). Statistical differences from pre- and 1 h post-values are described by # and ∧, respectively (
< 0.05). Data are mean ± SD.
NK-Cell subsets CMV status
Pre-values
Post-values 1 h post-values
Main effects statistic ( value)
Interactions statistic ( value) Time Age CMV Time × Age Time × CMV Age × CMV Time × Age × CMV Total NK-cells/ L #∧ # 157.7 (<0.001) 2.6 (0.108) 5.7 (0.019) 0.6 (0.557) 4.7 (0.019) 1.3 (0.252) 1.0 (0.357) Younger (23–39 yrs) − 166 ± 96 785 ± 337 130 ± 117 + 181 ± 97 595 ± 360 128 ± 84 Older (50–64 yrs) − 223 ± 56 987 ± 182 142 ± 57 + 189 ± 85 666 ± 242 153 ± 69 CD56dim (cells/ L) #∧ # 157.1 (<0.001) 2.8 (0.085) 5.6 (0.020) 0.7 (0.518) 4.7 (0.018) 1.7 (0.197) 1.1 (0.333) Younger (23–39 yrs) − 147 ± 91 738 ± 325 106 ± 100 + 162 ± 94 556 ± 357 112 ± 82 Older (50–64 yrs) − 205 ± 58 942 ± 184 125 ± 57 + 176 ± 79 631 ± 217 135 ± 54 CD56 bright (cells/ L) #∧ 25.2 (<0.001) 1.1 (0.291) 2.5 (0.114) <0.1 (0.999) 0.4 (0.687) <0.1 (0.834) 0.5 (0.636) Younger (23–39 yrs) − 19 ± 12 47 ± 27 24 ± 22 + 19 ± 9 39 ± 15 16 ± 7 Older (50–64 yrs) − 18 ± 9 45 ± 23 17 ± 6 + 13 ± 10 35 ± 31 18 ± 15 KLRG1+ (cells/ L) #∧ 72.6 (<0.001) 0.1 (0.773) 2.1 (0.153) 0.1 (0.929) 1.1 (0.335) 0.1 (0.788) 0.1 (0.948) Younger (23–39 yrs) − 98 ± 76 493 ± 240 80 ± 73 + 84 ± 70 334 ± 284 56 ± 64 Older (50–64 yrs) − 111 ± 45 481 ± 149 78 ± 13 + 95 ± 64 398 ± 198 69 ± 44 CD57+ (cells/ L) #∧ 98.5 (<0.001) 5.3 (0.023) 5.2 (0.024) 1.7 (0.196) 2.5 (0.084) 2.7 (0.105) 1.0 (0.360) Younger (23–39 yrs) − 63 ± 39 335 ± 190 53 ± 49 + 74 ± 48 310 ± 184 50 ± 32 Older (50–64 yrs) − 125 ± 29 578 ± 146 87 ± 29 + 110 ± 46 453 ± 109 80 ± 29 CD158a+ (cells/ L) #∧ 50.7 (<0.001) 0.9 (0.349) 2.7 (0.103) 0.3 (0.717) 1.3 (0.284) 0.2 (0.698) <0.1 (0.980) Younger (23–39 yrs) − 40 ± 25 228 ± 191 31 ± 34 + 40 ± 20 179 ± 87 28 ± 19 Older (50-64 yrs) − 51 ± 37 277 ± 91 32 ± 28 + 25 ± 16 119 ± 97 17 ± 15 CD8+ (cells/ L) #∧ 79.4 (<0.001) 8.4 (0.004) 1.2 (0.269) 2.7 (0.069) 1.7 (0.193) 4.8 (0.031) 3.0 (0.052) Younger (23–39 yrs) − 51 ± 35 184 ± 126 45 ± 46 + 61 ± 37 210 ± 94 42 ± 28 Older (50–64 yrs) − 94 ± 36 406 ± 159 62 ± 21 + 62 ± 43 200 ± 75 39 ± 22